Todd Pesavento
Overview
Explore the profile of Todd Pesavento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papanikolla J, McGowan M, Chunduru M, Winters H, Pesavento T, Smith R, et al.
Transpl Infect Dis
. 2024 Sep;
26(6):e14366.
PMID: 39226149
Background: There is limited literature describing the real-world practice of delayed initiation and shortened duration direct-acting antiviral (DAA) in kidney transplant recipients. We compared Hepatitis C virus (HCV) cure rates...
2.
Nolan A, McGowan M, Von Stein L, Ross A, Kaur M, Pesavento T, et al.
Clin Transplant
. 2023 Nov;
38(1):e15185.
PMID: 37937389
Background: With the availability of vaccines against SARS-COV-2, recommendations for vaccination of transplant candidates are widespread. At our institution, patients may receive liver transplant (LTx) regardless of vaccine status. The...
3.
Singh P, Von Stein L, McGowan M, Nolan A, Ross A, Kaur M, et al.
Clin Transplant
. 2023 Nov;
38(1):e15187.
PMID: 37933615
Introduction: We assessed differences in the post-transplant outcomes between COVID-19 vaccinated and unvaccinated Kidney transplant (KTx) recipients. Methods: We conducted a retrospective, single-center study of 400 KTx from 2/1/2021 to...
4.
Daloul R, Sureshkumar K, Schnelle K, Von Stein L, Logan A, Pesavento T
Clin Transplant
. 2022 Dec;
37(2):e14895.
PMID: 36580971
Background: Kidney transplantation from HCV-viremic donors into uninfected recipients is associated with excellent short-term outcomes. However, concerns regarding an increased risk for the development of de novo donor specific antibodies...
5.
Singh N, Doshi M, Schold J, Preczewski L, Klein C, Akalin E, et al.
Clin J Am Soc Nephrol
. 2022 Aug;
17(9):1372-1381.
PMID: 35914792
Background And Objectives: There are no standardized benchmarks to measure productivity and compensation of transplant nephrologists in the United States, and consequently, criteria set for general nephrologists are often used....
6.
Daloul R, Schnelle K, Von Stein L, Logan A, Singh P, Yenebere P, et al.
Transpl Infect Dis
. 2022 Jun;
24(4):e13887.
PMID: 35752929
Background: kidney transplantation from Hepatitis C virus (HCV) viremic donors to uninfected recipients is associated with excellent short-term outcomes. However, HCV viremia might be associated with an increased risk for...
7.
Botros M, Jackson K, Singh P, Rosenheck J, Ganapathi A, Henn M, et al.
Clin Transplant
. 2021 Dec;
36(4):e14568.
PMID: 34951933
Background: Acute kidney injury (AKI) is a common complication after lung transplantation (LT) and is associated with higher cost and mortality. We sought to evaluate the incidence of postoperative AKI,...
8.
Looking Beyond the Allograft Survival: Long-Term, 5-Year Renal Outcome in Lung Transplant Recipients
Doraiswamy M, Obole E, Botros M, Keller B, Pesavento T, Singh P
Transplant Proc
. 2021 Nov;
53(10):3065-3068.
PMID: 34756711
With the increased incidence and survival of lung transplant (LTx) recipients, the risk for chronic sequelae such as chronic kidney disease (CKD) is on the rise. Data on the long-term...
9.
Daloul R, Anthony M, Washburn K, Singh P, Pesavento T
Clin Nephrol
. 2021 Jun;
96(4):216-225.
PMID: 34169833
Materials And Methods: This was a prospective, non-randomized, pilot clinical study. 30 HCV-negative participants received kidney transplant from HCV-viremic deceased donors. HCV polymerase chain reaction (PCR) was checked on day...
10.
Daloul R, Braga J, Diez A, Logan A, Pesavento T
Kidney Int Rep
. 2021 Apr;
6(4):986-994.
PMID: 33912748
Introduction: Blood transfusion is a risk factor for allosensitization. Nevertheless, blood transfusion posttransplant remains a common practice. We evaluated the effect of posttransplant blood transfusion on graft outcomes. Methods: We...